Terran Biosciences Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$100M
- Investors
-
20
Terran Biosciences General Information
Description
Developer of a biotechnology platform designed to advance transformative therapeutics and technologies for neurological and psychiatric diseases. The company offers late-stage therapies for schizophrenia and serotonin 2A receptor antagonists, a proprietary drug design engine for psychedelic therapies, and AI-enabled imaging software, enabling patients with neurological and psychiatric conditions to achieve improved treatment outcomes.
Contact Information
Website
www.terranbiosciences.comCorporate Office
- Miami Beach, FL
- United States
Corporate Office
- Miami Beach, FL
- United States
Terran Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B) | 14-Apr-2022 | $100M | Completed | Generating Revenue | ||
| 4. Early Stage VC | 01-Feb-2021 | Completed | Generating Revenue | |||
| 3. Seed Round | 22-May-2020 | Completed | Generating Revenue | |||
| 2. Seed Round | 03-Oct-2019 | $9.4M | $10.8M | Completed | Generating Revenue | |
| 1. Seed Round | 01-Jan-2019 | $1.4M | $1.4M | Completed | Generating Revenue |
Terran Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Terran Biosciences Comparisons
Industry
Financing
Details
Terran Biosciences Competitors (6)
One of Terran Biosciences’s 6 competitors is Neurosterix, a Venture Capital-Backed company based in Geneva, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Neurosterix | Venture Capital-Backed | Geneva, Switzerland | ||||
| Neumora | Formerly VC-backed | Watertown, MA | ||||
| Definium Therapeutics | Formerly VC-backed | New York, NY | ||||
| COMPASS Pathways | Formerly VC-backed | Altrincham, United Kingdom | ||||
| GH Research | Formerly VC-backed | Dublin, Ireland |
Terran Biosciences Patents
Terran Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025174424-A1 | Analogs of xanomeline, analogs of trospium, and methods of use thereof | Pending | 16-Feb-2024 | ||
| US-12269818-B2 | Analogs of xanomeline | Active | 24-Apr-2023 | ||
| US-20240368149-A1 | Analogs of xanomeline | Active | 24-Apr-2023 | ||
| AU-2024263007-A1 | Prodrugs of xanomeline, prodrugs of trospium and methods of use thereof | Pending | 24-Apr-2023 | ||
| EP-4705289-A1 | Prodrugs of xanomeline, prodrugs of trospium and methods of use thereof | Pending | 24-Apr-2023 | C07D417/04 |
Terran Biosciences Signals
Terran Biosciences Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Brkfst Club | Venture Capital | Minority | ||
| Manta Capital Advisors | Venture Capital | Minority | ||
| Nettle Ventures | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Astir Ventures | Venture Capital | Minority |
Terran Biosciences Investments (2)
Terran Biosciences’s most recent deal was a Corporate Asset Purchase with Blumentech (Patent Portfolio and Accompanying Data). The deal was made on 13-Apr-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Blumentech (Patent Portfolio and Accompanying Data) | 13-Apr-2022 | Corporate Asset Purchase | Buildings and Property | ||
| Concert Pharmaceuticals (Portfolio Central Nervous System Assets) | 11-Mar-2022 | Corporate Asset Purchase | Pharmaceuticals |
Terran Biosciences Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Concert Pharmaceuticals (Portfolio Central Nervous System Assets) | Lexington, MA |
Terran Biosciences FAQs
-
When was Terran Biosciences founded?
Terran Biosciences was founded in 2017.
-
Where is Terran Biosciences headquartered?
Terran Biosciences is headquartered in Miami Beach, FL.
-
What is the size of Terran Biosciences?
Terran Biosciences has 6 total employees.
-
What industry is Terran Biosciences in?
Terran Biosciences’s primary industry is Biotechnology.
-
Is Terran Biosciences a private or public company?
Terran Biosciences is a Private company.
-
What is the current valuation of Terran Biosciences?
The current valuation of Terran Biosciences is .
-
What is Terran Biosciences’s current revenue?
The current revenue for Terran Biosciences is .
-
How much funding has Terran Biosciences raised over time?
Terran Biosciences has raised $113M.
-
Who are Terran Biosciences’s investors?
Brkfst Club, Manta Capital Advisors, Nettle Ventures, , and Astir Ventures are 5 of 20 investors who have invested in Terran Biosciences.
-
Who are Terran Biosciences’s competitors?
Neurosterix, Neumora, Definium Therapeutics, COMPASS Pathways, and GH Research are some of the 6 competitors of Terran Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process